On Dec. 7, 2016, FAREVA Richmond in Henrico, VA became the 11th aerosol facility in the FAREVA Group, with the inauguration of its new aerosol plant in the Richmond area. Following a first-phase investment of $40 million to produce drug, O-T-C and beauty products, the new installation includes:
- Three aerosol packaging lines, including one with “bag on valve” capability;
- A flame-proof bulk manufacturing workshop;
- All required utilities such as U.S. Pharmacopeia (USP) grade water, compressed air, steam and propellant gas storage;
- An R&D laboratory for the development of customers’ products.
The plant’s production capacity is 100 million aerosol cans, according to FAREVA, and will create between 80 to 100 jobs. A second phase is being considered, with the aim of installing up to four additional lines, increasing capacity to 250 million aerosol cans. It would require an additional investment of $15 to $20 million and create approximately 150 new jobs.
FAREVA Group, created and managed by Bernard Fraisse, is a subcontractor in the fields of Household & Industrial, Cosmetic and Pharmaceutical products with 35 sites worldwide, a turnover of more than $1.5 billion and a workforce of nearly 10,000 people.
In 2011, FAREVA expanded into the U.S. with the acquisition of the Pfizer manufacturing site in the Richmond, VA area. FAREVA Richmond employs 600 people across 745,000 sq ft of manufacturing and office space. While mastering a wide range of manufacturing technologies, FAREVA is an internationally recognized specialist in aerosol technology, the company stated, with 10 production sites worldwide: six in France, with the others in Turkey, the UK, Brazil and Russia.